Trial Profile
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia After Refractive Surgery
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 23 Apr 2021
Price :
$35
*
At a glance
- Drugs Riboflavin (Primary)
- Indications Keratoconus
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Avedro
- 12 Jun 2014 New trial record